ロード中...
Lamivudine-resistant rtL180M and rtM204I/V are persistently dominant during combination rescue therapy with entecavir and adefovir for hepatitis B
Adefovir (ADV) sequential monotherapy was included in the 2005 Asia-Pacific guidelines for the management of patients with lamivudine (LAM) resistance. However, following the development of ADV resistance, the proportion of resistant variants during combined rescue therapy with ADV and entecavir (ET...
保存先:
| 出版年: | Exp Ther Med |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
D.A. Spandidos
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4888018/ https://ncbi.nlm.nih.gov/pubmed/27313669 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2016.3230 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|